Research and analysis

COVID-19: PHE laboratory assessments of molecular tests

PHE has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.

From:
Public Health England
Published
4 June 2020
Last updated
22 February 2021 — See all updates

Documents

Rapid assessment: BGI Real-Time Fluorescent RT-PCR kit for detecting 2019-nCoV

Ref: PHE publications gateway number GW-1955 PDF, 514 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Biomerieux ARGENE® SARS-COV-2 R-GENE® real-time detection kit

Ref: PHE publications gateway number GW-1596 PDF, 670 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: careGENE N-CoV RT-PCR Kit

Ref: PHE publications gateway number: GW-1397 PDF, 213 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: COVID-19 Plus RealAmp kit

Ref: PHE publications gateway number: GW-1383 PDF, 264 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: GenMark ePlex SARS-CoV-2 test

Ref: PHE publications gateway number: GW-1384 PDF, 270 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment of selected commercial molecular diagnostic tests for the laboratory detection of COVID-19 infections

Ref: PHE publications gateway number: GW-1312 PDF, 422 KB, 14 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: ViaSure SARS-CoV-2 Real Time PCR detection Kit

Ref: PHE publications gateway number: GW-1316 PDF, 268 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Seegene ‘Allplex 2019-nCoV’ assay for the detection of SARS-CoV-2 (COVID-19)

Ref: PHE publications gateway number: GW-1316 PDF, 351 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Roche Ltd Coronavirus LightMix® Modular SARS and Wuhan CoV E-gene assay

Ref: PHE publications gateway number: GW-1316 PDF, 438 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Randox Extended Coronavirus Multiplex Array assay

Ref: PHE publications gateway number: GW-1316 PDF, 268 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Novacyt Primerdesign Coronavirus (COVID-19) genesig® Real-Time PCR assay

Ref: PHE publications gateway number: GW-1316 PDF, 267 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Liferiver Novel Coronavirus Real Time Multiplex RT-PCR Kit

Ref: PHE publications gateway number: GW-1316 PDF, 269 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Genetic Signatures EasyScreen™ SARS-CoV-2 Detection Kit

Ref: PHE publications gateway number: GW-1316 PDF, 350 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Genetic PCR solutions CoVID-19 dtec-RT-qPCR Test

Ref: PHE publications gateway number: GW-1316 PDF, 267 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: GeneFirst Novel Coronavirus (COVID-19) Real-Time PCR assay

Ref: PHE publications gateway number: GW-1316 PDF, 267 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: AusDiagnostics Coronavirus Typing assay for the detection of SARS-CoV-2 (COVID-19)

Ref: PHE publications gateway number: GW-1316 PDF, 267 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Altona RealStar RT-PCR Kit 1.0. assay for detection of SARS-CoV-2 (COVID-19)

Ref: PHE publications gateway number: GW-1316 PDF, 266 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Public Health England (PHE) has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.

Included here are:

  • a summary report for the laboratory assessments of COVID molecular diagnostic tests undertaken by PHE and completed in the period February and April 2020
  • a series of individual assay assessments
Published 4 June 2020
Last updated 22 February 2021 + show all updates

  1. Added: 'Rapid assessment: BGI Real-Time Fluorescent RT-PCR kit for detecting 2019-nCoV'.

  2. Added Rapid assessment of Biomerieux ARGENE® SARS-COV-2 R-GENE® real-time detection kit.

  3. Added rapid assessment: careGENE N-CoV RT-PCR Kit.

  4. Added rapid assessments: COVID-19 Plus RealAmp kit and GenMark ePlex SARS-CoV-2 test.

  5. First published.

Related content